OAM
NGNE icon

Oxford Asset Management’s Neurogene NGNE Stock Holding History

Oxford Asset Management’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,589
Closed -$148K – 1979
2019
Q3 		$148K Sell
2,589
-6,020
-70% -$367K ﹤0.01% 1604
2019
Q2 		$406K Sell
8,609
-2,001
-19% -$103K 0.01% 1353
2019
Q1 		$572K Sell
10,610
-2,767
-21% -$140K 0.01% 1154
2018
Q4 		$578K Buy
13,377
+637
+5% +$31K 0.02% 1132
2018
Q3 		$747K Buy
12,740
+6,544
+106% +$386K 0.02% 1146
2018
Q2 		$299K Buy
6,196
+3,888
+168% +$1.01M 0.01% 1496
2018
Q1 		$650K Buy
2,308
+547
+31% +$151K 0.01% 1136
2017
Q4 		$419K Buy
+1,761
New +$413K 0.01% 1237

Other funds holding NGNE

EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return